|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-8-14
|
|
pubmed:abstractText |
Efficacy of heparin and low-molecular-weight heparins (LMWHs) in inflammatory bowel disease (IBD) treatment has been suggested. The multimatrix oral formulation MMX releases active drugs in the colon, avoiding systemic absorption. Parnaparin sodium is the LMWH chosen to be carried in the MMX formulation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1365-2036
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
581-8
|
|
pubmed:meshHeading |
pubmed-meshheading:18700898-Administration, Oral,
pubmed-meshheading:18700898-Adolescent,
pubmed-meshheading:18700898-Adult,
pubmed-meshheading:18700898-Aged,
pubmed-meshheading:18700898-Anticoagulants,
pubmed-meshheading:18700898-Colitis, Ulcerative,
pubmed-meshheading:18700898-Delayed-Action Preparations,
pubmed-meshheading:18700898-Dose-Response Relationship, Drug,
pubmed-meshheading:18700898-Drug Administration Routes,
pubmed-meshheading:18700898-Female,
pubmed-meshheading:18700898-Heparin, Low-Molecular-Weight,
pubmed-meshheading:18700898-Humans,
pubmed-meshheading:18700898-Male,
pubmed-meshheading:18700898-Middle Aged,
pubmed-meshheading:18700898-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis.
|
|
pubmed:affiliation |
Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
